| Title : A phase 1, safety, tolerability, and pharmacokinetics study of bisnorcymserine, a highly selective inhibitor of butyrylcholinesterase - Tzieras_2026_Neurotherapeutics_23_e00918 |
| Author(s) : Tzieras I , Manolopoulos A , Tweedie D , Luo W , Maccecchini M , Egan JM , Greig NH , Kapogiannis D |
| Ref : Neurotherapeutics , 23 :e00918 , 2026 |
| Abstract : |
| PubMedSearch : Tzieras_2026_Neurotherapeutics_23_e00918 |
| PubMedID: 42127455 |
| Gene_locus related to this paper: human-BCHE |